The Efficacy, Tolerance and Acceptance of a New Fixed-Dose Salmeterol and Fluticasone Propionate Dry-Powder Inhaler—Salflumix Easyhaler^® in COPD Patients in the Daily Clinical Practice

The efficacy of the fix-dose salmeterol/fluticasone propionate combination in chronic obstructive pulmonary disease (COPD) was only shown for the original product. This investigator-initiated study aimed to prove the efficacy and safety of Salflumix Easyhaler^®, a second-entry product (dry...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Zbigniew Doniec, Magdalena Olszanecka-Glinianowicz, Piotr Hantulik, Agnieszka Almgren-Rachtan, Jerzy Chudek
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2022-11-01
Schriftenreihe:	Applied Sciences
Schlagworte:	chronic obstructive pulmonary disease fix-dose salmeterol/fluticasone propionate combination generic
Online-Zugang:	https://www.mdpi.com/2076-3417/12/23/12142
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!